Elderly colon cancer patients are being given the chance to access a clinical trial led by the University of Leeds that could ...

Ipilimumab, a cancer immunotherapy, reduced scar formation and promoted tissue regeneration in a mouse model of idiopathic ...

During a live event, Ahmad Tarhini, MD, PhD, discussed key melanoma trials with varying survival and toxicity profiles.

The world of oncology is evolving rapidly, with breakthrough technologies transforming the way cancer is treated and managed.

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...

Oncology nurses can encourage clinical trial enrollment for patients with anaplastic thyroid cancer, a rare and aggressive ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The global oncolytic virus cancer therapy market is poised for exceptional growth, expanding from an estimated USD 36.87 million in 2025 to an impressive USD 386.89 million by 2035, marking a Compound ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...